A. Otani

1.1k total citations
18 papers, 876 citations indexed

About

A. Otani is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A. Otani has authored 18 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 9 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A. Otani's work include Retinal Diseases and Treatments (11 papers), Angiogenesis and VEGF in Cancer (5 papers) and Glaucoma and retinal disorders (5 papers). A. Otani is often cited by papers focused on Retinal Diseases and Treatments (11 papers), Angiogenesis and VEGF in Cancer (5 papers) and Glaucoma and retinal disorders (5 papers). A. Otani collaborates with scholars based in Japan, United States and Brazil. A. Otani's co-authors include Hitoshi Takagi, Kiyoshi Suzuma, Hideyasu Oh, Miyo Matsumura, Kazuhiro Ishida, Yuichiro Ogura, Chieko Takagi, Yuki Honda, Nagahisa Yoshimura and Manabu Sasahara and has published in prestigious journals such as American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science and British Journal of Ophthalmology.

In The Last Decade

A. Otani

17 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Otani Japan 12 630 361 304 65 63 18 876
Ryoichi Arita Japan 15 625 1.0× 320 0.9× 496 1.6× 42 0.6× 67 1.1× 28 969
S. Kawahara Japan 13 468 0.7× 343 1.0× 439 1.4× 35 0.5× 39 0.6× 23 862
Muneki Miura Japan 12 550 0.9× 413 1.1× 531 1.7× 25 0.4× 36 0.6× 15 946
Peter A. Campochiaro United States 11 866 1.4× 618 1.7× 398 1.3× 26 0.4× 38 0.6× 14 1.2k
Ayako Yoshida Japan 14 495 0.8× 324 0.9× 324 1.1× 44 0.7× 123 2.0× 18 912
Masafumi Kurimoto Japan 18 812 1.3× 617 1.7× 436 1.4× 35 0.5× 34 0.5× 26 1.2k
Hirokazu Nishiwaki Japan 19 760 1.2× 212 0.6× 390 1.3× 28 0.4× 61 1.0× 37 1.0k
Sylvia W. Y. Chiang Hong Kong 20 719 1.1× 416 1.2× 283 0.9× 18 0.3× 53 0.8× 35 1.0k
Sentaro Kusuhara Japan 21 1.1k 1.8× 320 0.9× 720 2.4× 15 0.2× 46 0.7× 96 1.4k
Yanyan Bai United States 13 227 0.4× 276 0.8× 128 0.4× 21 0.3× 57 0.9× 23 575

Countries citing papers authored by A. Otani

Since Specialization
Citations

This map shows the geographic impact of A. Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Otani more than expected).

Fields of papers citing papers by A. Otani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Otani. The network helps show where A. Otani may publish in the future.

Co-authorship network of co-authors of A. Otani

This figure shows the co-authorship network connecting the top 25 collaborators of A. Otani. A scholar is included among the top collaborators of A. Otani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Otani. A. Otani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Oishi, Akio, Ken Ogino, Satoko Nakagawa, et al.. (2013). Longitudinal analysis of the peripapillary retinal nerve fiber layer thinning in patients with retinitis pigmentosa. Eye. 27(5). 597–604. 16 indexed citations
2.
Nakanishi, Hideo, Akitaka Tsujikawa, Yuko Yodoi, et al.. (2011). Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization. Eye. 25(3). 375–381. 51 indexed citations
3.
Takayama, Kanako, Sotaro Ooto, Hiroshi Tamura, et al.. (2010). Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia. Eye. 24(9). 1492–1497. 26 indexed citations
4.
Hasegawa, Tomoko, et al.. (2010). Prognostic Factors of Vitreous Hemorrhage Secondary to Exudative Age-Related Macular Degeneration. American Journal of Ophthalmology. 149(2). 322–329.e1.
5.
Nakanishi, Hideo, Noriko Gotoh, Ryo Yamada, et al.. (2009). ARMS2/HTRA1 and CFH polymorphisms are not associated with choroidal neovascularization in highly myopic eyes of the elderly Japanese population. Eye. 24(6). 1078–1084. 19 indexed citations
6.
Oishi, Akio, A. Otani, Manabu Sasahara, et al.. (2008). Retinal nerve fiber layer thickness in patients with retinitis pigmentosa. Eye. 23(3). 561–566. 43 indexed citations
7.
Iwama, Daisuke, A. Otani, Manabu Sasahara, et al.. (2008). Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone. British Journal of Ophthalmology. 92(10). 1352–1356. 3 indexed citations
8.
Oishi, Akio, A. Otani, Manabu Sasahara, et al.. (2008). Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa. Eye. 23(6). 1411–1416. 55 indexed citations
9.
Sasahara, Manabu, A. Otani, Yuko Yodoi, et al.. (2008). Circulating hematopoietic stem cells in patients with choroidal neovascularization secondary to pathologic myopia. Eye. 23(3). 718–726. 1 indexed citations
10.
Oishi, Akio, Hajime Nakamura, Manabu Sasahara, et al.. (2008). Optical coherence tomographic pattern and focal electroretinogram in patients with retinitis pigmentosa. Eye. 23(2). 299–303. 26 indexed citations
11.
Tamura, Hiroshi, Akitaka Tsujikawa, A. Otani, et al.. (2007). Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography. British Journal of Ophthalmology. 91(9). 1152–1159. 35 indexed citations
12.
Dorrell, Michael I., Edith Aguilar, A. Otani, & M. Friedländer. (2003). R-Cadherin Blocking Peptides Disrupt Vascular Patterning and Targeting of Bone-Marrow Derived Hematopoeitic Stem Cells in the Developing Mouse Retinal Vasculature. Investigative Ophthalmology & Visual Science. 44(13). 2093–2093. 1 indexed citations
13.
Otani, A., Hitoshi Takagi, Hideyasu Oh, et al.. (2000). Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes.. PubMed. 41(5). 1192–9. 99 indexed citations
14.
Otani, A., et al.. (1999). Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.. PubMed. 40(9). 1912–20. 100 indexed citations
15.
FAVA, L. R. G., et al.. (1999). The C-shaped root canal system and its endodontic implications: a clinical review.. PubMed. 2(3). 18–22, 24. 1 indexed citations
16.
Oh, Hideyasu, Hitoshi Takagi, Chieko Takagi, et al.. (1999). The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.. PubMed. 40(9). 1891–8. 329 indexed citations
17.
Suzuma, Kiyoshi, et al.. (1998). Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.. PubMed. 39(6). 1028–35. 67 indexed citations
18.
Otani, A. & H. Remmer. (1975). Proceedings: Participation of microsomal NADPH-cytochrome C reductase in the metabolism of rifampicin.. PubMed. 287 Suppl. R76–R76. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026